Information Technology
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Unlock global pharma market insights with cutting-edge IT solutions. Discover AI, data analytics, and digital transformation for pharma BD & investment.
Showing 1–9 of 9 articles
Quick answer
NovaPharmaNews Information Technology hub for FDA covers 9 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Genstar-backed Signant Health Acquires Ametris: Implications for eCOA and Digital Outcome Measures
Opinion: The medical-billing AI arms race between providers and insurance
INTERPHEX 2026: Avantor, BioLife Solutions, AES Highlights
FDA Real-World Evidence: Transforming US Drug Development Strategies
Glaukos Receives Permanent J-Code J2789 for Epioxa™ Ophthalmic Treatment, Effective July 2026
FDA Blockchain Pilot Program: Enhancing Pharmaceutical Supply Chain Security
FDA to Launch AI-Powered Drug Review System by 2027
FDA Digital Health Innovation Plan: Impact on SaMD Approvals
Blockchain in Pharmaceutical Supply Chain: Ensuring Drug Safety with FDA Insights
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.